SMS Pharmaceuticals Ltd — Interim / Quarterly Report 2023

May 24, 2023

Thirumalesh Digitally signed by Thirumalesh Tumma Tumma Date: 2023.05.24 17:11:43 +05'30'

SMS PHARMACEUTICALS LIMITED

						SMS PHARMACEUTICALS LIMITED	SMS PHARMACEUTICALS LIMITED	SMS PHARMACEUTICALS LIMITED	SMS PHARMACEUTICALS LIMITED	SMS PHARMACEUTICALS LIMITED	SMS PHARMACEUTICALS LIMITED	SMS PHARMACEUTICALS LIMITED	SMS PHARMACEUTICALS LIMITED	SMS PHARMACEUTICALS LIMITED	SMS PHARMACEUTICALS LIMITED	SMS PHARMACEUTICALS LIMITED	SMS PHARMACEUTICALS LIMITED	SMS PHARMACEUTICALS LIMITED
						Disclosure of Related Party Transactions for the halfyear ended 31st March 2023(Rs. in Lakhs)
											Additional disclosure of related party transactions ‐ applicable only in case the related party transaction relates to loans, inter‐corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Sr no	Details of the party (listed entity /subsidiary) entering into the transaction		Details of the counterparty			Type of related party transaction	Value of the related party transaction as approved by the audit committee	Value of transaction during the reporting period	In case monies are due to either party as a result of the transaction		In case any financial indebtedness is incurred to make or give loans, inter‐ corporate deposits, advances or investments			Details of the loans, inter‐corporate deposits, advances or investments
	Name	PAN	Name	PAN	Relationship of the counterparty with the listed entity or its subsidiary				Opening balance	Closing balance	Nature of indebtedness (loan/ issuance of debt/ any other etc.)	Cost	tenure	Nature (loan/ advance/ inter‐ corporate deposit/ investment	Interest Rate (%)	Tenure	Secured/un secured	Purpose for which the funds will be utilised by the ultimate recipient
1	SMS Pharmaceutical s Limited		VKT Pharma Private Limited		Associate Company	Sale ofgoods	14,750.00	623.01	512.52	1,085.97
						Purchase of goods	200.00	62.31	512.52	1,085.97
						Rent Received	50.00	12.78	512.52	1,085.97
2			SMS Lifesciences India Limited		Promoters holding more than 10 % of total equity	Purchase of goods	2,000.00	719.05	‐48.87	‐540.99
3			Raghavendra Engineering Industries Private Limited		Relative of Promoter	Purchase of goods	1,500.00	26.20	3.65	‐12.76
						Sale of goods	150.00	‐	3.65	‐12.76
4			Eshwar Coal Movers		Relative of Promoter	Purchase of goods	500.00	95.48	‐79.67	‐64.80
5			Ramesh Babu Potluri		Key Management Personnel	Remuneration Paid		151.38	12.30	10.30
6			Vamsi Krishna potluri		Key Management Personnel	Remuneration Paid		33.03	3.02	0.32
7			Lakshmi Narayana T		Key Management Personnel	Remuneration Paid		11.66	1.57	1.75
8			Thirumalesh T		Key Management Personnel	Remuneration Paid		7.53	1.06	0.97
	Notes: 1.The value of the related party transactions with VKT Pharma Private Limited, the amount approved by the Audit Committe/ Board of Directors/ Shareholders of SMS Pharmaceuticals Limited for the period from the conculsion of the 34th AGM held in the year 2022 to till the conclusiton of the 35th AGM to be held in the year 2023. 2. The PAN details are not to be included in the disclosure pursuant to guidance note issued by the Stock Exchanges. 3.Dividend paid by SMS Pharmaceuticals Limited to related parties is not included in statement above since payment of dividend by a listed company is not a related party transaction as per Regulation 2(1)(zc) of the SEBI LODR Regulations. 4. The above statement does not include the Sitting Fee paid to the Directors of SMS Pharmaceuticals Limited